Top Markets
#1 Official Trump Official Trump +37.23%
#2 Tutorial Tutorial +30.77%
#3 Siacoin Siacoin +23.62%
#4 EXOD EXOD +22.08%
#5 Melania Meme Melania Meme +21.46%
#6 MowCat MowCat +18.74%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +17.16%
#8 Mubarak Mubarak +16.28%
#9 Stacks Stacks +16.22%
#10 Unit Pump Unit Pump +15.68%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
Rank in Stocks #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
Share Price
$0.04959193
Last synced: 2025-03-17
Market Cap
$79.94M
Change (1 day)
13.49%
Change (1 year)
0.00%
Country
SE
Trade Abliva AB (publ) (ABLI)

Category

Healthcare
Stock price history for Abliva AB (publ) (ABLI)
Highest end of day price: $0.04 on 2025-03-01

Lowest end of day price: $0.44 on 2008-10-01
Stock price history of Abliva AB (publ) from 2008 to 2026
Annual Stock Price Performance
Year Performance
2025 83.38%
2024 -0.37%
2023 44.87%
2022 -73.02%
2021 -34.26%
2020 -30.47%
2019 -20.24%
2018 -46.40%
2017 4.60%
2016 -62.61%
2015 -86.83%
2014 208.88%
2013 -8.57%
2012 59.62%
2011 -55.60%
2010 208.76%
2009 91.09%
2008 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH